With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Single-cell multi-omics integration across gene expression, protein abundance and chromatin accessibility remains challenging. The authors present scMAGCA, an interpretable framework for integrating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results